Efficacy and safety of alendronic acid in the treatment of osteoporosis in children

Autor: Martín Siguero,Alberto, Áreas Del Águila,Vera Lucía, Franco Sereno,María Teresa, Fernández Marchante,Ana Isabel, Pérez Serrano,Raúl, Encinas Barrios,Carmen

Publikováno v: Farmacia Hospitalaria, Vol 39, Iss 6, Pp 350-357 (2015)
Farmacia Hospitalaria v.39 n.6 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname

to describe the efficacy and safety of the off-label use of alendronate in the treatment of osteoporosis in children and adolescents.a retrospective study (2008-2014) of all patients under 18 years who were dispensed alendronate for this indication.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::55a59cf801dfc2ff7fc158e578a5b906
http://www.aulamedica.es/fh/pdf/9037.pdf

Excipientes de declaración obligatoria (EDO): una obligación no resuelta

Autor: Martín Siguero,A., Tudela Patón,P., Pérez Serrano,R., Encinas Barrios,C.

Publikováno v: Farmacia Hospitalaria v.38 n.2 2014
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::f21fc50eb3cc949fac029ef6012ac3ba
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432014000200013

PS-093 Pharmaceutical intervention to prevent metformin-associated lactic acidosis in diabetics admitted with kidney failure

Autor: AI Fernández Marchante, R. Pérez Serrano, M.L. Moreno Perulero, C Encinas Barrios, A.M. Alañón Pardo, MM Alañón Pardo, A Martín Siguero, E Vila Torres, MT Franco Sereno, I Benet Giménez

Publikováno v: European Journal of Hospital Pharmacy. 22:A173.1-A173

Background Metformin is widely used against diabetes type II mellitus. Its most severe adverse effect is lactic acidosis. Although rare, the risk of its development can be increased by kidney failure (KF). Purpose To report on pharmaceutical interven

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bf9cb9b88e65621995cc137954b57c72
https://doi.org/10.1136/ejhpharm-2015-000639.416

CP-140 Implementation of antibiotic treatment protocols in the ICU: results after a year

Autor: H. Abdel-Hadi Álvarez, C Encinas Barrios, R. Pérez Serrano, MT Franco Sereno, R. del Campo Tejedor, A. Ambrós Checa, A Martín Siguero, AI Fernández Marchante

Publikováno v: European Journal of Hospital Pharmacy. 22:A56.1-A56

Background In 2012, treatment protocols were agreed for the most common infections (pneumonia, urinary tract, bacteraemia and intra-abdominal catheter), approved by the relevant Committees and implemented in the Intensive Care Unit (ICU). Purpose Thi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0ac1cf11ec4743f61557effd4efcef23
https://doi.org/10.1136/ejhpharm-2015-000639.134

OHP-033 Satisfaction survey of patients with interferon beta 1-a device

Autor: VL Areas del Águila, A Martín Siguero, MM Alañón Pardo, MT Franco Sereno, C Encinas Barrios, AI Fernández Marchante, BM Muñoz Cejudo, C Blázquez Romero

Publikováno v: European Journal of Hospital Pharmacy. 21:A198.3-A199

Background Satisfaction surveys are an important tool for ascertaining patient opinions. Purpose To evaluate the degree of satisfaction with interferon beta-1a pre-filled pens and patient preferences. Materials and methods We conducted a survey of pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::27d46e8a0cf5cafcc50d44da8dd62bca
https://doi.org/10.1136/ejhpharm-2013-000436.485